Literature DB >> 30133696

On doubly robust estimation of the hazard difference.

Oliver Dukes1, Torben Martinussen2, Eric J Tchetgen Tchetgen3, Stijn Vansteelandt1.   

Abstract

The estimation of conditional treatment effects in an observational study with a survival outcome typically involves fitting a hazards regression model adjusted for a high-dimensional covariate. Standard estimation of the treatment effect is then not entirely satisfactory, as the misspecification of the effect of this covariate may induce a large bias. Such misspecification is a particular concern when inferring the hazard difference, because it is difficult to postulate additive hazards models that guarantee non-negative hazards over the entire observed covariate range. We therefore consider a novel class of semiparametric additive hazards models which leave the effects of covariates unspecified. The efficient score under this model is derived. We then propose two different estimation approaches for the hazard difference (and hence also the relative chance of survival), both of which yield estimators that are doubly robust. The approaches are illustrated using simulation studies and data on right heart catheterization and mortality from the SUPPORT study.
© 2018, The International Biometric Society.

Entities:  

Keywords:  Additive hazards model; Causal inference; Doubly robust estimation; Lifetime and survival analysis; Semiparametric inference

Mesh:

Year:  2018        PMID: 30133696      PMCID: PMC7735191          DOI: 10.1111/biom.12943

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  8 in total

1.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

2.  On doubly robust estimation in a semiparametric odds ratio model.

Authors:  Eric J Tchetgen Tchetgen; James M Robins; Andrea Rotnitzky
Journal:  Biometrika       Date:  2009-12-08       Impact factor: 2.445

3.  On adjustment for auxiliary covariates in additive hazard models for the analysis of randomized experiments.

Authors:  S Vansteelandt; T Martinussen; E Tchetgen Tchetgen
Journal:  Biometrika       Date:  2013-11-21       Impact factor: 2.445

4.  ON ESTIMATION OF THE OPTIMAL TREATMENT REGIME WITH THE ADDITIVE HAZARDS MODEL.

Authors:  Suhyun Kang; Wenbin Lu; Jiajia Zhang
Journal:  Stat Sin       Date:  2018-07       Impact factor: 1.261

5.  Doubly Robust Additive Hazards Models to Estimate Effects of a Continuous Exposure on Survival.

Authors:  Yan Wang; Mihye Lee; Pengfei Liu; Liuhua Shi; Zhi Yu; Yara Abu Awad; Antonella Zanobetti; Joel D Schwartz
Journal:  Epidemiology       Date:  2017-11       Impact factor: 4.822

6.  The hazards of hazard ratios.

Authors:  Miguel A Hernán
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

7.  The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators.

Authors:  A F Connors; T Speroff; N V Dawson; C Thomas; F E Harrell; D Wagner; N Desbiens; L Goldman; A W Wu; R M Califf; W J Fulkerson; H Vidaillet; S Broste; P Bellamy; J Lynn; W A Knaus
Journal:  JAMA       Date:  1996-09-18       Impact factor: 56.272

8.  Structural Nested Cumulative Failure Time Models to Estimate the Effects of Interventions.

Authors:  Sally Picciotto; Miguel A Hernán; John H Page; Jessica G Young; James M Robins
Journal:  J Am Stat Assoc       Date:  2012       Impact factor: 5.033

  8 in total
  5 in total

1.  Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies.

Authors:  Rohan Khera; Martijn J Schuemie; Yuan Lu; Anna Ostropolets; RuiJun Chen; George Hripcsak; Patrick B Ryan; Harlan M Krumholz; Marc A Suchard
Journal:  BMJ Open       Date:  2022-06-09       Impact factor: 3.006

2.  The effects of midazolam or propofol plus fentanyl on ICU mortality: a retrospective study based on the MIMIC-IV database.

Authors:  Wen Sun; Yang Yan; Shidong Hu; Boyan Liu; Shuying Wang; Wenli Yu; Songyan Li
Journal:  Ann Transl Med       Date:  2022-02

3.  Adjusting for time-varying confounders in survival analysis using structural nested cumulative survival time models.

Authors:  Shaun Seaman; Oliver Dukes; Ruth Keogh; Stijn Vansteelandt
Journal:  Biometrics       Date:  2019-11-07       Impact factor: 2.571

4.  Using generalized linear models to implement g-estimation for survival data with time-varying confounding.

Authors:  Shaun R Seaman; Ruth H Keogh; Oliver Dukes; Stijn Vansteelandt
Journal:  Stat Med       Date:  2021-05-04       Impact factor: 2.373

5.  Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis.

Authors:  Jue Hou; Nicole Kim; Tianrun Cai; Kumar Dahal; Howard Weiner; Tanuja Chitnis; Tianxi Cai; Zongqi Xia
Journal:  JAMA Netw Open       Date:  2021-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.